Skip to main content

Novo Nordisk A S

NONOF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0000353278

No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $5.36M in total; no superinvestor holds it.

Other share classesNVO

13F holders, Q4 2025

Institutional positions in Novo Nordisk A S as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
2
−1 vs. Q3 2025
Shares held
5.28K
−15.5K (−74.6%) vs. Q3 2025
Total value
$269.4K
−$855.3K (−76.0%) vs. Q3 2025
New holders
1
0 more added
Sold out
2
0 more reduced

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NONOF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 2 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 2 institutionsQ4 2023: 2 institutionsQ1 2024: 3 institutionsQ2 2024: 3 institutionsQ3 2024: 2 institutionsQ4 2024: 3 institutionsQ1 2025: 2 institutionsQ2 2025: 3 institutionsQ3 2025: 3 institutionsQ4 2025: 2 institutionsQ1 2026: 3 institutionsQ2 2026: 3 institutions
Value heldQ4 2025: $269.4K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $4.09MQ4 2023: $4.18MQ1 2024: $14.3MQ2 2024: $24.5MQ3 2024: $643.4KQ4 2024: $1.39MQ1 2025: $849.3KQ2 2025: $43.2MQ3 2025: $1.12MQ4 2025: $269.4KQ1 2026: $13.9MQ2 2026: $5.36M
Institutions holding NONOF and their total value by quarter
QuarterHoldersValue
Q2 20263$5.36M
Q1 20263$13.9M
Q4 20252$269.4K
Q3 20253$1.12M
Q2 20253$43.2M
Q1 20252$849.3K
Q4 20243$1.39M
Q3 20242$643.4K
Q2 20243$24.5M
Q1 20243$14.3M
Q4 20232$4.18M
Q3 20232$4.09M
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Novo Nordisk A S; share changes are against Q3 2025.

Institutions holding NONOF in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Atlas Capital Advisors LLC5,218$266.4K0.03%+5,218New
Steigerwald, Gordon & Koch Inc.60$3.06K0.00%00.0%Unchanged
Saranac Partners Ltd0$00.00%−13,431−100.0%Sold out
LBMC Investment Advisors, LLC0$00.00%−7,250−100.0%Sold out